查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
MCD（多种癌症诊断）测试：全球市场展望
市场调查报告书
商品编码
1423536

MCD（多种癌症诊断）测试：全球市场展望

Multi-Cancer Diagnostic Tests: Global Market Outlook
出版日期: | 出版商: BCC Research | 英文 50 Pages | 订单完成后即时交付

价格

本报告调查了全球MCD（多种癌症诊断）检测市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析以及新兴技术趋势。我们总结了趋势，竞争形势、主要企业简介等。

目录

第一章简介

第 2 章摘要/亮点

  • 市场展望
  • 市场摘要

第三章市场与技术背景

  • 生物标誌物的类型
  • 前景

第四章市场动态

  • 市场动态简介
  • 市场驱动因素
  • 癌症筛检中未满足的需求
  • 政府癌症筛检倡议
  • 市场抑制因素
  • 误报或漏报的风险
  • 监管和报销的不确定性

第五章市场区隔：依测试类型

  • 全球 MCD（多种癌症诊断）检测市场：按检测类型
  • 市场规模/预测
  • 实验室开发的测试
  • 体外诊断测试

第六章市场细分：依最终用户分类

  • 全球 MCD（多种癌症诊断）测试市场：按最终用户划分
  • 医院
  • 诊断实验室
  • 研究机构

第七章市场细分：依地区

  • 全球 MCD（多种癌症诊断）检测市场：按地区
  • 美国
  • 欧洲
  • 新兴市场

第八章新兴技术

  • 组织来源的识别
  • 片段组学和肿瘤教育血小板
  • 液体活体组织切片与影像资料分析

第9章 竞争形势

  • 波特五力分析
  • 最近的趋势
  • 临床试验活动

第十章 公司简介

  • ANCHORDX MEDICAL CO. LTD.
  • BURNING ROCK BIOTECH LTD.
  • DELFI DIAGNOSTICS
  • EXACT SCIENCES CORP.
  • FREENOME HOLDINGS INC.
  • GENECAST INC.
  • GRAIL INC.
  • GUARDANT HEALTH INC.
Product Code: MDS101A

Highlights:

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Report Scope:

The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented into laboratory-developed tests and in-vitro diagnostic tests based on test type. The market is segmented into diagnostic laboratories, hospitals and research institutions based on end user. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products. The study does not include single cancer early detection tests and detection tests for targeted therapies.

The regional markets covered are U.S., Europe and emerging markets.

Revenues are broken down by region, type and end user. For market estimates, data has been provided for 2020 and 2021 as historic years, 2022 as the base year, 2023 and a forecast for 2028.

Report Includes:

  • An overview of the global market for the multi-cancer diagnostic tests
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the current and future market potential of multi-cancer detection tests along with a detailed analysis of the drivers and challenges in the market
  • Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by test type, end-user, and region
  • Overview of the significant driving trends and challenges that affect the global market and its vendor landscape
  • Discussion of sustainability trends and ESG developments in the multi-cancer diagnostic tests market, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed
  • Information pertaining to the recent developments and upcoming technologies in the market
  • An analysis of the market competitive landscape featuring the company revenue share analyses, recent mergers and acquisition activities, and venture funding outlook
  • Company profiles of the major global players

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of the Report
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary

Chapter 3 Market and Technology Background

  • Introduction
  • Types of Biomarkers
  • Future Outlook

Chapter 4 Market Dynamics

  • Market Dynamics Snapshot
  • Market Drivers
  • Unmet Needs in Cancer Screening
  • Government Measures for Cancer Screening
  • Market Restraints
  • Risk of False Positives or False Negatives
  • Regulatory and Reimbursement Uncertainty

Chapter 5 Market Breakdown by Test Type

  • Global Multi-Cancer Diagnostic Test Market, by Test Type
  • Market Size and Forecast
  • Laboratory Developed Tests
  • In-Vitro Diagnostic Tests

Chapter 6 Market Breakdown by End User

  • Global Multi-Cancer Diagnostic Test Market, by End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions

Chapter 7 Market Breakdown by Region

  • Global Multi-Cancer Diagnostic Test Market, by Region
  • The U.S.
  • Europe
  • Emerging Markets

Chapter 8 Emerging Technologies

  • Introduction
  • Identification of Tissue of Origin
  • Fragmentomics and Tumor-Educated Platelets
  • Liquid Biopsy with Imaging Data Analysis

Chapter 9 Competitive Landscape

  • Porter's Five Forces Analysis
  • Threat of New Entrants
  • Threat of Substitutes
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Degree of Competition
  • Recent Developments in the Multi-Cancer Diagnostic Market
  • Clinical Trial Activities

Chapter 10 Company Profiles

  • ANCHORDX MEDICAL CO. LTD.
  • BURNING ROCK BIOTECH LTD.
  • DELFI DIAGNOSTICS
  • EXACT SCIENCES CORP.
  • FREENOME HOLDINGS INC.
  • GENECAST INC.
  • GRAIL INC.
  • GUARDANT HEALTH INC.

List of Tables

  • Summary Table A : Global Multi-Cancer Diagnostic Test Market, Through 2028
  • Summary Table B : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
  • Table 1 : Cancer Screening Guidelines
  • Table 2 : Global Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 3 : Global Multi-Cancer Diagnostic Test Market, by Laboratory Developed Tests Type, by Region, Through 2028
  • Table 4 : Global Multi-Cancer Diagnostic Test Market, by In-Vitro Diagnostic Test Type, by Region, Through 2028
  • Table 5 : Global Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 6 : Global Multi-Cancer Diagnostic Test Market Used in Hospitals, by Region, Through 2028
  • Table 7 : Global Multi-Cancer Diagnostic Test Market Used in Diagnostic Laboratories, by Region, Through 2028
  • Table 8 : Global Multi-Cancer Diagnostic Test Market Used in Research Institutions, by Region, Through 2028
  • Table 9 : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
  • Table 10 : The U.S. Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 11 : The U.S. Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 12 : European Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 13 : European Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 14 : Emerging Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
  • Table 15 : Emerging Multi-Cancer Diagnostic Test Market, by End User, Through 2028
  • Table 16 : Emerging Multi-Cancer Diagnostic Test Market, by Country, Through 2028
  • Table 17 : Porter's Five Force Analysis of the Multi-Cancer Diagnostic Test Market
  • Table 18 : Recent Developments in Multi-Cancer Diagnostics, 2022 and 2023
  • Table 19 : Ongoing Clinical Trials for Multi-Cancer Diagnostic Tests
  • Table 20 : MCD Technologies of Competitor Products
  • Table 21 : AnchorDx Medical Co. Ltd.: Company Snapshot
  • Table 22 : Burning Rock Biotech Ltd.: Company Snapshot
  • Table 23 : Delfi Diagnostics Inc.: Company Snapshot
  • Table 24 : Exact Sciences Corp.: Company Snapshot
  • Table 25 : Freenome Holdings Inc.: Company Snapshot
  • Table 26 : Genecast Inc.: Company Snapshot
  • Table 27 : Grail Inc.: Company Snapshot
  • Table 28 : Guardant Health Inc.: Company Snapshot

List of Figures

  • Summary Figure A : Global Multi-Cancer Diagnostic Test Market, 2020-2028
  • Summary Figure B : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
  • Figure 1 : Potential Benefits of Multi-Cancer Diagnostic Tests
  • Figure 2 : Multi-Cancer Diagnostic Tests Market Dynamics
  • Figure 3 : Evidence Generation Required for Multi-Cancer Diagnostic Tests
  • Figure 4 : Global Multi-Cancer Diagnostic Test Market, by Test Type, 2020-2028
  • Figure 5 : Global Multi-Cancer Diagnostic Test Market Share, by Test Type, 2022
  • Figure 6 : Global Multi-Cancer Diagnostic Test Market, by End User, 2020-2028
  • Figure 7 : Global Multi-Cancer Diagnostic Test Market Share, by End User, 2022
  • Figure 8 : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
  • Figure 9 : Global Multi-Cancer Diagnostic Test Market Share, by Region, 2022
  • Figure 10 : Emerging Technologies in the Multi-Cancer Diagnosis Test Market